mRNA |
navitoclax:sorafenib (1:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
-0.012 |
0.7 |
mRNA |
bid1870 |
gCSI |
pan-cancer |
AAC |
0.018 |
0.7 |
mRNA |
NSC 74859 |
CTRPv2 |
pan-cancer |
AAC |
-0.012 |
0.7 |
mRNA |
UNC0638:navitoclax (1:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.012 |
0.7 |
mRNA |
cyanoquinoline 11 |
CTRPv2 |
pan-cancer |
AAC |
-0.017 |
0.7 |
mRNA |
Bortezomib |
gCSI |
pan-cancer |
AAC |
0.019 |
0.8 |
mRNA |
VU0155056 |
CTRPv2 |
pan-cancer |
AAC |
0.012 |
0.8 |
mRNA |
PRIMA-1-Met |
CTRPv2 |
pan-cancer |
AAC |
0.017 |
0.8 |
mRNA |
BRD-A02303741:navitoclax (2:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.011 |
0.8 |
mRNA |
austocystin d |
CTRPv2 |
pan-cancer |
AAC |
0.012 |
0.8 |